Table 5.
Relationship Between SUVmax and the Expression of Glut-1 or HK-II in Patients of Pancreatic Cancer. There was no Significant Difference in SUVmax Between Tumors That Exhibited Negative and Positive Glut-1 Expression (P > .05). The Same was True for Tumors That Exhibited Negative and Positive HK-II Expression. (P > .05)
| Patients of Pancreatic Cancer | SUVmax | P Value (t-Test) |
|---|---|---|
| Glut-1 negative group | 5.0 ± 2.8 | 0.661 |
| Glut-1 positive group | 5.5 ± 3.0 | |
| HK-2 negative group | 5.7 ± 2.6 | 0.664 |
| HK-2 negative group | 5.4 ± 3.1 |